Trending Medical and health breaking news EMA Panel Endorses Two Cancer Drugs, One Sickle Cell Drug

Trending Medical and well being breaking information EMA Panel Endorses Two Most cancers Medicine, One Sickle Cell Drug

Two cancer drugs and one drug to treat sickle cell disease will likely reach the European market soon, following approval recommendations from a European Medicines Agency (EMA) panel. The drugs are enfortumab vedotin (Padcev, Astellas/Seagen) for urothelial cancer, tepotinib (Tepmetko, Merck) for non-small cell lung cancer (NSCLC), and voxelotor (Oxbryta, Global Blood Therapeutics) for sickle…